Beta Glass Plc (NGX:BETAGLAS)

Checkpoint Therapeutics Income Statement

Financials in millions NGN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	134,436	117,580	62,905	54,340	36,983	25,637
Revenue Growth (YoY)	86.12%	86.92%	15.76%	46.93%	44.26%	-12.84%
Cost of Revenue	91,539	87,152	50,698	43,927	27,809	19,733
Gross Profit	42,897	30,428	12,208	10,414	9,173	5,904
Selling, General & Admin	7,051	6,419	3,759	3,452	2,348	1,814
Other Operating Expenses	-2,166	-1,124	274	-600.59	-882.01	-316.61
Operating Expenses	6,581	6,991	4,533	2,880	1,467	1,526
Operating Income	36,315	23,437	7,674	7,534	7,707	4,378
Interest Expense	-10,100	-9,782	-2,010	-630.71	-244.64	-203.58
Interest & Investment Income	9,121	8,121	2,084	1,241	597.14	537.23
Currency Exchange Gain (Loss)	-1,815	-1,742	1,794	-1,285	-763.35	285.5
Other Non Operating Income (Expenses)	-512.21	-169.43	-107.66	-	-17.6	-0
EBT Excluding Unusual Items	33,009	19,865	9,434	6,858	7,278	4,997
Gain (Loss) on Sale of Investments	-	-	-	-	-59.23	-
Gain (Loss) on Sale of Assets	51.25	38.76	11.23	132.83	219.87	117.72
Pretax Income	33,061	19,903	9,445	6,991	7,439	5,115
Income Tax Expense	10,878	6,277	3,003	2,306	1,981	1,648
Net Income	22,183	13,627	6,442	4,685	5,458	3,467
Net Income to Common	22,183	13,627	6,442	4,685	5,458	3,467
Net Income Growth	270.34%	111.52%	37.49%	-14.15%	57.43%	-37.88%
Shares Outstanding (Basic)	600	600	600	600	600	600
Shares Outstanding (Diluted)	600	600	600	600	600	600
EPS (Basic)	36.97	22.71	10.74	7.81	9.10	5.78
EPS (Diluted)	36.97	22.71	10.74	7.81	9.10	5.78
EPS Growth	270.34%	111.52%	37.49%	-14.15%	57.43%	-37.88%
Free Cash Flow	8,698	9,780	3,784	-4,172	3,724	282.32
Free Cash Flow Per Share	14.50	16.30	6.31	-6.95	6.21	0.47
Dividend Per Share	2.950	2.950	1.400	1.170	0.917	0.867
Dividend Growth	110.71%	110.71%	19.66%	27.63%	5.77%	-37.72%
Gross Margin	31.91%	25.88%	19.41%	19.16%	24.80%	23.03%
Operating Margin	27.01%	19.93%	12.20%	13.86%	20.84%	17.08%
Profit Margin	16.50%	11.59%	10.24%	8.62%	14.76%	13.52%
Free Cash Flow Margin	6.47%	8.32%	6.02%	-7.68%	10.07%	1.10%
EBITDA	42,239	28,922	11,717	11,651	10,978	6,902
EBITDA Margin	31.42%	24.60%	18.63%	21.44%	29.68%	26.92%
D&A For EBITDA	5,924	5,485	4,043	4,117	3,271	2,524
EBIT	36,315	23,437	7,674	7,534	7,707	4,378
EBIT Margin	27.01%	19.93%	12.20%	13.86%	20.84%	17.08%
Effective Tax Rate	32.90%	31.54%	31.79%	32.98%	26.63%	32.22%

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.